Impact of Postoperative Pyuria on Treatment Outcomes After PVP

N/AUnknownNCT02241902

DongGuk University120 enrolled

Overview

The aim of this study was to identify serial changes in the incidence of postoperative pyuria after the Photoselective Vaporization of the Prostate (PVP), to determine whether the presence of postoperative pyuria could be correlated with surgical outcomes after surgery and to identify predicting factors that influence on persistent pyuria after the PVP.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Prostatic Hyperplasia Pyuria

Eligibility

Sex: MALEMin age: 40 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * men who underwent photoselective vaporization (PVP) using 80 watt potassium-titanyl-phosphate (KTP) laser or 120 watt high-power-system (HPS) laser for benign prostatic hyperplasia refractory to medical treatment * sterile urine on urinalysis and urine culture before surgery * absence of indwelling urethral catheter before surgery Exclusion Criteria: * previous diagnosis of prostate carcinoma or bladder cancer * co-existence of urinary stone * any antibiotic treatment within 2-weeks before surgery

Locations (1)

Dongguk University ilsan Hospital

Goyang-si, Gyeonggi-do, South Korea

RECRUITING

Outcomes

Primary Outcomes

Change in the subtotal storage symptoms score of the International Prostate Symptom Score (IPSS)

Time frame: 1-week, and 1-, 3- and 6-months after the surgery

Central Contacts

Min Chul Cho, M.D., Ph.D.

CONTACT

82-31-961-7456 cmc1206@empal.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.